Literature DB >> 11911311

Hepatectomy for metastases from non-colorectal and non-neuroendocrine tumor.

H Yamada1, H Katoh, S Kondo, S Okushiba, T Morikawa.   

Abstract

BACKGROUND: The role of hepatectomy for metastases from non-colorectal (NCR) and non-neuroendocrine (NNE) tumors has not been defined. We analyzed several factors of the primary tumor and liver metastases to clarify the prognostic determinants. PATIENTS AND METHODS: From 1990 to 1995, 33 patients underwent hepatectomy for metastases from NCR and NNE tumors. The primary tumors were gastric cancer in 9, biliary cancer in 7, pancreatic cancer in 6, breast cancer in 4 and miscellaneous tumor in 7 patients.
RESULTS: The overall 5-year survival after hepatectomy was 12.1%. Morbidity and mortality rates were 21.2% and 9.1%, respectively. The liver metastases from breast cancer, unilateral liver metastases and curative resection of liver metastases were prognostic factors in univariate analysis.
CONCLUSION: Resection of liver metastases from NCR and NNE tumors may offer prolonged survival for selected patients.

Entities:  

Mesh:

Year:  2001        PMID: 11911311

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review.

Authors:  Timothy L Fitzgerald; Jason Brinkley; Shannon Banks; Nasreen Vohra; Zachary P Englert; Emmanuel E Zervos
Journal:  Langenbecks Arch Surg       Date:  2014-08-23       Impact factor: 3.445

2.  Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.

Authors:  Jürgen Weitz; Leslie H Blumgart; Yuman Fong; William R Jarnagin; Michael D'Angelica; Lawrence E Harrison; Ronald P DeMatteo
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

3.  Non-colorectal, non-neuroendocrine, and non-sarcoma metastases of the liver: resection as a promising tool in the palliative management.

Authors:  Moritz Schmelzle; Claus F Eisenberger; Jan Schulte am Esch; Hanno Matthaei; Markus Krausch; Wolfram T Knoefel
Journal:  Langenbecks Arch Surg       Date:  2009-12-09       Impact factor: 3.445

4.  Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model.

Authors:  René Adam; Laurence Chiche; Thomas Aloia; Dominique Elias; Rémy Salmon; Michel Rivoire; Daniel Jaeck; Jean Saric; Yves Patrice Le Treut; Jacques Belghiti; Georges Mantion; Gilles Mentha
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

5.  Preoperative Prognostic Factors After Liver Resection for Non-Colorectal, Non-Neuroendocrine Liver Metastases and Validation of the Adam Score in an Asian Population.

Authors:  Dayna P Y Sim; Brian K P Goh; Ser-Yee Lee; Chung-Yip Chan; Iain B H Tan; Peng-Chung Cheow; Premaraj Jeyaraj; Pierce K H Chow; London L P J Ooi; Alexander Y F Chung
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

6.  Surgical treatment of liver metastases from pancreatic cancer.

Authors:  Hidehisa Yamada; Satoshi Hirano; Eiichi Tanaka; Toshiaki Shichinohe; Satoshi Kondo
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 7.  Operative mortality after hepatic resection: are literature-based rates broadly applicable?

Authors:  Bolanle Asiyanbola; David Chang; Ana Luiza Gleisner; Hari Nathan; Michael A Choti; Richard D Schulick; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-02-12       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.